Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial.
暂无分享,去创建一个
D. Torigian | M. Soulen | B. Levine | C. June | J. Melenhorst | M. O'Hara | S. Lacey | G. Plesa | G. Beatty | Farzana Nazimuddin | Fang Chen | I. Kulikovskaya | M. McGarvey | A. Nelson | W. Gladney | J. Melenhorst